Symbol="GMAB"
AssetType="Common Stock"
Name="Genmab AS"
Description="Genmab A / S develops antibody therapies for the treatment of cancer and other diseases mainly in Denmark. The company is headquartered in Copenhagen, Denmark."
CIK="1434265"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="TOLDBODGADE 33, 1253 COPENHAGEN K, DK"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="24641313000"
EBITDA="6661000000"
PERatio="32.27"
PEGRatio="1.21"
BookValue="41.69"
DividendPerShare="0"
DividendYield="0"
EPS="1.17"
RevenuePerShareTTM="23.46"
ProfitMargin="0.345"
OperatingMarginTTM="0.412"
ReturnOnAssetsTTM="0.143"
ReturnOnEquityTTM="0.212"
RevenueTTM="15330000000"
GrossProfitTTM="14595000000"
DilutedEPSTTM="1.17"
QuarterlyEarningsGrowthYOY="-0.513"
QuarterlyRevenueGrowthYOY="0.347"
AnalystTargetPrice="44.3"
TrailingPE="32.27"
ForwardPE="35.34"
PriceToSalesRatioTTM="2.463"
PriceToBookRatio="8.01"
EVToRevenue="2.203"
EVToEBITDA="3.589"
Beta="0.648"
num_52WeekHigh="47.5"
num_52WeekLow="31.4"
num_50DayMovingAverage="39.54"
num_200DayMovingAverage="39.52"
SharesOutstanding="652750000"
DividendDate="None"
ExDividendDate="None"
symbol="GMAB"
open="38.00"
high="38.00"
low="37.62"
price="37.75"
volume="498405.00"
latest_trading_day="2023-07-11"
previous_close="37.86"
change="-0.11"
change_percent="-0.2905%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="48"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="52"
Volume_recent_avg="445976"
Change_recent_avg="0.02"
Delta_recent_avg="0.6"
Variance_recent_avg="0.3"
Change_ratio_recent_avg="0.06"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="52"
Aroon_momentum_negative="48"
image_negative_thumbnail_id_1="517"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0088.jpeg"
image_negative_thumbnail_id_2="144"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0032.jpeg"
image_neutral_thumbnail_id_1="542"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_neutral_thumbnail_id_2="532"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0067.jpeg"
image_positive_thumbnail_id_1="640"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0068.jpeg"
image_positive_thumbnail_id_2="639"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0069.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
